✦ LIBER ✦

Is Clostridium difficile infection a particular problem after reversal of ileostomy?

✍ Scribed by J. K. Randall; B. C. Young; G. Patel; A. Fitzgerald; B. D. George

Book ID: 109043643
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 13
Category: Article
ISSN: 1462-8910
DOI: 10.1111/j.1463-1318.2009.02139.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The undiagnosed cases of Clostridium dif

The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?

✍ L. Alcalá; A. Martín; M. Marín; M. Sánchez-Somolinos; P. Catalán; T. Peláez; E. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Clostridium difficile is no longer just

Clostridium difficile is no longer just a nosocomial infection or an infection of adults

✍ Hanna Pituch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Risk factors and incidence of Clostridiu

Risk factors and incidence of Clostridium difficile infection after colorectal surgery

✍ Messick, Craig A.; Manilich, Elena; Sun, Chao; Hammel, Jeffery P.; Costedio, Mea 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Clostridium difficile Infection and Cand

Clostridium difficile Infection and Candida Colonization of the Gut: Is There a Correlation?

✍ Raponi, G.; Visconti, V.; Brunetti, G.; Ghezzi, M. C. 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 335 KB

Outcomes of Patients Who Develop Symptom

Outcomes of Patients Who Develop Symptomatic Clostridium difficile Infection After Solid Organ Transplantation

✍ O.M. Mitu-Pretorian; B. Forgacs; A. Qumruddin; A. Tavakoli; T. Augustine; R. Par 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Rifaximin for the treatment of recurrent

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

✍ Guy Neff; Victoria Zacharias; Tiffany E. Kaiser; Amy Gaddis; Nyingi Kemmer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Previous data have suggested that the nonsystemic antibiotic rifaximin may be effective for the treatment of Clostridium difficile infection (CDI). This single-center retrospective study evaluated the efficacy of rifaximin for the treatment of CDI refractory to standard treatments in patients who ha